Belgrade’s Torlak Institute’s Sputnik vaccine approved in Russia

Serbia will be the first country in Europe outside Russia to produce the vaccine, the government stated. The initial ‘validation series’ of the vaccine from Torlak was sent for inspection last month to the Gamaleya institute. [Shutterstock/Steve Heap]

Russia’s Gamaleya National Institute for Epidemiology and Microbiology has certified the quality of the vaccine produced in the Torlak Institute for Virology, Vaccines and Sera in Belgrade, and has approved the production of the Sputnik V vaccine in that institute, the Serbian government announced on Wednesday.

Serbia will be the first country in Europe outside Russia to produce the vaccine, the government stated. The initial validation series of the vaccine from Torlak was sent for inspection last month to the Gamaleya institute. 

Serbian government minister, Nenad Popović has stated that the Russian institute had verified that the vaccines produced in Torlak satisfied the prescribed quality criteria, adding that the Russian partners had allowed Serbia to proceed with production.

A large quantity of the agents for the production of both components of the Sputnik V vaccine is expected to arrive in Serbia within the next two weeks.  (EURACTIV.rs | betabriefing.com)

Subscribe to our newsletters

Subscribe